Related Experiment Video
Updated: May 30, 2026

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
Published on: September 16, 2025
Comparing homatropine and atropine in pediatric cycloplegic refractions
Bhavin M Shah1, Pradeep Sharma, Vimla Menon
1Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Insights
Atropine provides more consistent cycloplegic refraction results in children than homatropine. A new formula may allow homatropine to achieve atropine-like outcomes in pediatric eye exams.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Pharmacology
Background:
- Accurate refractive error assessment in children is crucial for timely intervention.
- Cycloplegic agents are essential for relaxing accommodation during pediatric eye exams.
- Homatropine and atropine are commonly used cycloplegic agents with differing efficacy profiles.
Purpose of the Study:
- To compare the cycloplegic efficacy of homatropine and atropine in pediatric refractions.
- To develop a regression formula for predicting refraction findings using both agents.
Main Methods:
- Pediatric participants (4-10 years) with refractive error underwent cycloplegic refraction.
- Two percent homatropine and 1% atropine were administered.
- Refractive data analyzed using power vector analysis, including spherical equivalent and astigmatic components.
Main Results:
- Atropine revealed significantly greater hyperopic spherical equivalent in hypermetropic children compared to homatropine.
- Atropine demonstrated a significantly greater overall blur strength than homatropine.
- Homatropine resulted in significantly greater residual accommodation than atropine.
Conclusions:
- Atropine offers more consistent cycloplegic refraction results in pediatric patients.
- While atropine has a slower onset and longer duration, a derived regression formula may enable homatropine to achieve similar outcomes.
- This formula could enhance the clinical utility of homatropine in pediatric eye care.
Purpose:
To compare cycloplegic efficacy of homatropine and atropine in pediatric refractions and derive a regression formula to calculate refraction findings for both agents.
Methods:
Children between the ages of 4 to 10 years with refractive error underwent cycloplegic refraction with 2% homatropine and 1% atropine by retinoscopy and automated refraction. Refractive data were compared by the use of power vector analysis. Primary outcome measures were spherical equivalent (SE), astigmatic components of refractive error (J(0) and J(45)), overall blur strength of refractive error, and residual accommodation.
Results:
A total of 63 children with refractive error were enrolled (mean age, 6.7 ± 1.6 years). Compared with homatropine, atropine uncovered significantly greater hyperopic SE in patients with hypermetropia (4.2 ± 2.5 D [atropine] vs 3.5 ± 2.3 D [homatropine]; P < 0.001) as well as myopia (-1.8 ± 1.4 D [atropine] vs -2.1 ± 1.4 D [homatropine]; P < 0.001). Overall blur strength was significantly greater with atropine (3.1 ± 2.1 [atropine] vs 2.9 ± 1.9 [homatropine]; P = 0.003). Homatropine had a significantly greater residual accommodation (1.8 ± 0.4 D [atropine] vs 3.1 ± 0.5 D [homatropine]; P < 0.001). A regression formula was derived.
Conclusions:
Of the 2 cycloplegic agents, atropine yielded more consistent results than homatropine; however atropine had a relatively slow onset and prolonged effect. Our regression formula may make it possible to derive atropine-like results while using the clinically more versatile homatropine.
Related Concept Videos
¹H NMR Chemical Shift Equivalence: Homotopic and Heterotopic Protons
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Properties of Enantiomers and Optical Activity
